Cargando…
Type II alveolar cell MHCII improves respiratory viral disease outcomes while exhibiting limited antigen presentation
Type II alveolar cells (AT2s) are critical for basic respiratory homeostasis and tissue repair after lung injury. Prior studies indicate that AT2s also express major histocompatibility complex class II (MHCII) molecules, but how MHCII expression by AT2s is regulated and how it contributes to host de...
Autores principales: | Toulmin, Sushila A., Bhadiadra, Chaitali, Paris, Andrew J., Lin, Jeffrey H., Katzen, Jeremy, Basil, Maria C., Morrisey, Edward E., Worthen, G. Scott, Eisenlohr, Laurence C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239023/ https://www.ncbi.nlm.nih.gov/pubmed/34183650 http://dx.doi.org/10.1038/s41467-021-23619-6 |
Ejemplares similares
-
Standard screening methods underreport AAV-mediated transduction and gene editing
por: Lang, Jonathan F., et al.
Publicado: (2019) -
MHCII glycosylation modulates Bacteroides fragilis carbohydrate antigen presentation
por: Ryan, Sean O., et al.
Publicado: (2011) -
Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts
por: Kerdidani, Dimitra, et al.
Publicado: (2022) -
A universal MHCII technology platform to characterize antigen-specific CD4(+) T cells
por: Vyasamneni, Rohit, et al.
Publicado: (2023) -
Fraction of MHCII and EpCAM expression characterizes distal lung epithelial cells for alveolar type 2 cell isolation
por: Hasegawa, Koichi, et al.
Publicado: (2017)